CHE - Chemed Corporation
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Aveanna Healthcare (AVAH) or Chemed (CHE). But which of these two stocks is more attractive to value investors?
Chemed Corporation (CHE) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2026 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2026.
CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2026 annual stockholders' meeting.
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Prepared Remarks Transcript
CINCINNATI, May 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, at approximately 8:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City.
Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcript
CINCINNATI, May 05, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2026 Health Care Conference on Tuesday, May 12, 2026, at 3:00 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations).
Chemed stock jumps after Q1 earnings and revenues beat estimates despite margin contraction and mixed segment performance across VITAS and Roto-Rooter.
Chemed (NYSE: CHE - Get Free Report) and LifeStance Health Group (NASDAQ: LFST - Get Free Report) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability. Institutional and Insider Ownership 95.9% of Chemed
Cwm LLC boosted its holdings in shares of Chemed Corporation (NYSE: CHE) by 88.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,084 shares of the company's stock after purchasing an additional 1,914 shares during the period. Cwm LLC's holdings in
Abacus FCF Advisors LLC bought a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 13,871 shares of the company's stock, valued at approximately $5,935,000. Abacus FCF Advisors LLC owned 0.10% of Chemed at
Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript
Chemed (CHE) came out with quarterly earnings of $5.65 per share, beating the Zacks Consensus Estimate of $5.17 per share. This compares to earnings of $5.63 per share a year ago.
Full-Year Guidance Increased Due To: Strong VITAS Performance Re-purchase of 500,000 Shares in the Quarter Two Roto-Rooter Franchises Purchased for $20.6 Million CINCINNATI, April 23, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2026, versus the comparable prior-year period. Results for Quarter Ended March 31, 2026 Consolidated operating results: Revenue increased 1.6% to $657.5 million GAAP Diluted Earnings-per-Share (EPS) of $4.84, a decrease of 0.4% Adjusted Diluted EPS of $5.65, an increase of 0.4% VITAS segment operating results: Net Patient Revenue of $420.0 million, an increase of 3.1% Average Daily Census (ADC) of 22,723, an increase of 2.2% Admissions of 19,394, an increase of 6.9% Net Income, excluding certain discrete items, of $52.2 million, an increase of 4.4% Adjusted EBITDA, excluding Medicare Cap, of $70.8 million, an increase of 0.6% Adjusted EBITDA margin, excluding Medicare Cap, of 16.8%, a decrease of 41-basis points Roto-Rooter segment operating results: Revenue of $237.5 million, a decrease of 0.9% Net Income, excluding certain discrete items, of $37.7 million, a decrease of 9.7% Adjusted EBITDA of $53.5 million, a decline of 9.6% Adjusted EBITDA margin of 22.5%, a decline of 218-basis points VITAS VITAS net revenue was $420.0 million in the first quarter of 2026, which is an increase of 3.1% when compared to the prior-year period.
Evergreen Capital Management LLC lowered its position in shares of Chemed Corporation (NYSE: CHE) by 19.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,244 shares of the company's stock after selling 4,018 shares during the quarter. Evergreen Capital Management
On April 21, 2026, Chemed Corp (CHE) shares fell 3.1% to $373.79, continuing a downward trend with a year-to-date loss of 12.5%. The stock has traded between a
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CPAC, EPC and CHE have been added to the Zacks Rank #5 (Strong Sell) List on April 15, 2026.